Skip to main content
Equibles

Ikarian Capital, LLC

Position in ALEC — Alector, Inc.

CIK 1778253 DALLAS, TX
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,985,038
-$492,564 QoQ
Shares Held
1,982,606
-4.8% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#16
of 140 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Derivatives in ALEC

reported options exposure · as of Jun 30, 2021
CallValue
$464,509
CallShares
22,300
PutValue
$464,509
PutShares
22,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. ALEC ranks #44 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in ALEC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,985,038 1,982,606
2026-03-31 $4,477,602 2,082,606
2025-12-31 $3,248,865 2,082,606
2025-09-30 $2,249,600 760,000
2025-06-30 $1,260,000 900,000
2025-03-31 $1,168,500 950,000
2024-12-31 $1,795,500 950,000
2021-06-30 $464,509 22,300
2021-06-30 $464,509 22,300
2021-06-30 $14,054,480 674,723
2021-03-31 $5,186,050 257,500
2020-12-31 $869,975 57,500
2020-09-30 $3,381 321